Updated 07 August 2026 · HodieLabs Clinical Governance Lead · The HodieLabs Evidence-Based Clinical Library
A pro-inflammatory cytokine linked to chronic inflammation and autoimmune conditions. TNF-alpha is measured by blood test as part of the Inflammation panel in the HodieLabs Health Blueprint.
TNF-α is technically difficult to measure. Short half-life and pre-analytical sensitivity. Visceral fat is a major source of TNF-α production, reducing VAT directly lowers levels.
Associated risks when out of range: Chronically elevated TNF-α drives insulin resistance, muscle wasting, and bone loss. Central mediator of inflammatory cascades in autoimmune diseases.
The HodieLabs Evidence-Based Clinical Library classifies TNF-alpha as an emerging adjunctive evidence-tier biomarker. Its reference ranges come from a published authority standard rather than from observational optimisation targets. The standard used here is Systemic inflammation biomarker consensus; TNF-α <8.0 pg/mL reflects lower pro-inflammatory cytokine burden. Where relevant clinical outcomes are noted on this page, they reflect the guideline literature referenced below.
The HodieLabs Evidence-Based Clinical Library interprets TNF-alpha against published clinical authority standards, never arbitrary "optimal" ranges. Measured in pg/mL:
Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.
TNF-alpha is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.
1. Systemic inflammation biomarker consensus; TNF-α <8.0 pg/mL reflects lower pro-inflammatory cytokine burden.
This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.
A pro-inflammatory cytokine linked to chronic inflammation and autoimmune conditions.
The HodieLabs Evidence-Based Clinical Library optimal range is <8.0 pg/mL, based on Systemic inflammation biomarker consensus; TNF-α <8.0 pg/mL reflects lower pro-inflammatory cytokine burden.
Annual testing is recommended for most adults as part of a comprehensive preventative panel; more often if a result is being actively managed.
Evidence-supported levers include: anti-inflammatory lifestyle: omega-3, exercise, weight loss, sleep optimisation, investigate for chronic infection or autoimmune conditions if persistently elevated. Interpretation and an action plan should always involve your doctor.
TNF-alpha is measured in the HodieLabs Health Blueprint at our Melbourne Preventative Health and Longevity Clinic at 85 Spring Street, with doctor-led interpretation against evidence-based reference ranges.
TNF-alpha and 50+ biomarkers, measured and doctor-interpreted at our Melbourne clinic.